3she: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3she.jpg|left|200px]] | |||
The | <!-- | ||
The line below this paragraph, containing "STRUCTURE_3she", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
--> | |||
{{STRUCTURE_3she| PDB=3she | SCENE= }} | |||
===Novel ATP-competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series=== | |||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_22119462}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 22119462 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_22119462}} | |||
==About this Structure== | |||
[[3she]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3SHE OCA]. | |||
==Reference== | |||
<ref group="xtra">PMID:022119462</ref><references group="xtra"/> | |||
[[Category: Homo sapiens]] | |||
[[Category: Non-specific serine/threonine protein kinase]] | |||
[[Category: Kazemier, B.]] | |||
[[Category: Oubrie, A.]] | |||
[[Category: Kinase domain with bound inhibitor]] | |||
[[Category: Transferase-transferase inhibitor complex]] | |||
Revision as of 14:38, 14 December 2011
Novel ATP-competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the seriesNovel ATP-competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series
Template:ABSTRACT PUBMED 22119462
About this StructureAbout this Structure
3she is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Oubrie A, Kaptein A, de Zwart E, Hoogenboom N, Goorden R, van de Kar B, van Hoek M, de Kimpe V, van der Heijden R, Borsboom J, Kazemier B, de Roos J, Scheffers M, Lommerse J, Schultz-Fademrecht C, Barf T. Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series. Bioorg Med Chem Lett. 2011 Nov 3. PMID:22119462 doi:10.1016/j.bmcl.2011.10.071